Related Experiment Video
Updated: Jul 6, 2026

Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity
Published on: June 7, 2017
Resveratrol induces the suppression of tumor-derived CD4+CD25+ regulatory T cells
Yoolhee Yang1, Jin Ho Paik, Daeho Cho
1Department of Life Science, Sookmyung Women's University, Hyochangwon-gil 52, Yongsan-gu, Seoul 140-742, Republic of Korea.
Abstract:
CD4+CD25+ regulatory T cells (Treg cells) are negative regulator of the immune system and main obstacles to cancer immunotherapy in tumor-bearing hosts. Resveratrol is a natural product found in grapes with both immunomodulatory and anticancer effects, which can be controlled by Treg cells. Therefore, to determine whether resveratrol performs these actions via Treg cells, we investigated changes in Treg cell population and immunomodulatory cytokines in EG7 tumor-bearing C57BL/6 mice. In the present study, CD4+CD25+ cell population among CD4+ cells was inhibited ex vivo by resveratrol treatment in a dose-dependent manner. FoxP3+ expressing cells among CD4+CD25+ population were significantly reduced after resveratrol treatment ex vivo in intracellular FACS analysis. Single intraperitoneal administration of 4 mg/kg resveratrol suppressed the CD4+CD25+ cell population among CD4+ cells and downregulated secretion of TGF-beta, an immunosuppressive cytokine, measured from the spleens of tumor-bearing mice. Furthermore, resveratrol enhanced IFN-gamma expression in CD8+ T cells both ex vivo and in vivo,leading to immune stimulation. Taken together, these results suggest that resveratrol has a suppressive role on CD4+CD25+ cell population and makes peritumoral microenvironment unfavorable to tumor in tumor-bearing mice. Thus, resveratrol can be considered as possible adjuvant material for vaccination-based cancer therapy.
Insights
Resveratrol, a compound from grapes, suppresses regulatory T cells (Treg cells) and enhances immune responses. This suggests resveratrol could be a valuable adjuvant for cancer immunotherapy.
Area of Science:
- Immunology
- Cancer Research
- Pharmacology
Background:
- CD4+CD25+ regulatory T cells (Treg cells) suppress immune responses and hinder cancer immunotherapy.
- Resveratrol, a natural compound, exhibits immunomodulatory and anticancer properties.
- The role of resveratrol in modulating Treg cells in cancer remains to be fully elucidated.
Purpose of the Study:
- To investigate the effect of resveratrol on Treg cell populations and immunomodulatory cytokines in a mouse cancer model.
- To determine if resveratrol's effects are mediated through Treg cell modulation.
- To assess resveratrol's potential as an adjuvant for cancer therapy.
Main Methods:
- EG7 tumor-bearing C57BL/6 mice were treated with resveratrol.
- Flow cytometry (FACS) was used to analyze CD4+CD25+ cell populations and FoxP3 expression.
- Cytokine levels (TGF-beta and IFN-gamma) were measured in spleen cells.
Main Results:
- Resveratrol inhibited CD4+CD25+ cell populations ex vivo in a dose-dependent manner.
- Resveratrol treatment reduced FoxP3+ cells and TGF-beta secretion in vivo.
- Resveratrol enhanced IFN-gamma expression in CD8+ T cells, indicating immune stimulation.
Conclusions:
- Resveratrol suppresses Treg cells and downregulates immunosuppressive cytokines in tumor-bearing mice.
- Resveratrol promotes an anti-tumor immune response by enhancing CD8+ T cell activity.
- Resveratrol shows promise as an adjuvant material for vaccination-based cancer therapy.
Related Concept Videos
Tumor Immunotherapy
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Replicative Cell Senescence
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...